Vanc Pharmaceuticals, Inc.

Vanc Pharmaceuticals, Inc.

Vanc Pharmaceuticals, Inc.

Overview
Date Founded

2000

Headquarters

789 West Pender Street,Suite 810,Vancouver, BC V6C 1H2

Type of Company

Public

Employees (Worldwide)

2

Industries

Pharmaceuticals

Company Description

Avricore Health, Inc. engages in the manufacture and distribution of generic and over-the-counter (OTC) pharmaceutical products. It firm operates through the Products and Point of Care business division. The Products business division offers OTC pharmaceutical through its Corozon platform. The Point of Care business division provides point of care screening services through its HealthTab system and software platform. Its products include Hema-fer, Cortivera, and Sennace. The company was founded on May 30, 2000 and is headquartered in Vancouver, Canada.

Executives & Employees

President, Chief Executive Officer & Director

Chief Executive Officer

President & Director

Chief Financial Officer

Director, Pharmacy Solutions

Executive Consultant

Regulatory Affairs Associate

Medical Affairs Associate

Head-Investor Relations

Board of Directors

Former President, Chief Executive Officer & Director at RepliCel Life Sciences, Inc.

President & Director at Vanc Pharmaceuticals, Inc.

Professor at University of British Columbia

Former Senior Vice President at George Weston Limited

Director at Vanc Pharmaceuticals, Inc.

Paths to Vanc Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Vanc Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

Vanc Pharmaceuticals, Inc. purchases HealthTab, Inc.

Details Hidden

Vanc Pharmaceuticals, Inc. issued CAD Common Stock

Transaction Advisors
Legal Advisor

Advised onVanc Pharmaceuticals, Inc. issued CAD Common Stock

Auditor

Advised onVanc Pharmaceuticals, Inc. issued CAD Common Stock

Underwriter

Advised onVanc Pharmaceuticals, Inc. issued CAD Common Stock

Clients

Emerald Health Therapeutics, Inc. is a pharmaceutical company, which engages in the production and sale of cannabis products. Its products include dried cannabis and cannabis oil, pants and seeds. The company was founded on Jul 31, 2007 and is headquartered in Vancouver, Canada.

Key Stats and Financials As of 2018
Market Capitalization
$749K
Total Enterprise Value
$3.3M
Earnings Per Share
$-0.12
Revenue
$226K
EBITDAMargin
-1,153.71%
Net Profit
$-4.14M
Total Debt
$0
EBITDA
$-2.61M
Total Equity
$886K
Three Year Compounded Annual Growth Rate Of Revenue
240.95%
Debt TEV
0x
TEVNet Income
-0.8x
Enterprise Value Sales
14.58x
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vanc Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vanc Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Vanc Pharmaceuticals, Inc..